Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: HTO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on HTO, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 1,759,602 HTO shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,759,602 shares
    Change vs previous 13F -489,427 shares

    1.96% of the 13F portfolio, value $106,931,014.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 2,249,029 shares
    Change vs previous 13F +1,865,124 shares

    2.54% of the 13F portfolio, value $131,950,531.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 383,905 shares
    Change vs previous 13F not available

    0.39% of the 13F portfolio, value $18,808,916.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).